Cost-Effectiveness of Therapeutic Drug Monitoring-Guided Adalimumab Therapy in Rheumatic Diseases: A Prospective, Pragmatic Trial

INTRODUCTION: To assess the clinical and cost-effectiveness of therapeutic drug monitoring (TDM) based on serum adalimumab levels compared to standard of care in patients with rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis. METHODS: This was a non-inferiority, multicentric, non...

Descripción completa

Detalles Bibliográficos
Autores principales: Gómez-Arango, Catalina, Gorostiza, Inigo, Úcar, Eduardo, García-Vivar, Maria Luz, Pérez, Clara Eugenia, De Dios, Juan Ramon, Alvarez, Belen, Ruibal-Escribano, Ana, Stoye, Claudia, Vasques, Margarida, Belzunegui, Joaquin, Escobar, Antonio, Trancho, Ziortza, Ruiz del Agua, Ainhoa, Del Rio, Lorena, Jorquera, Cristina, Diez, Eli, Martínez, Antonio, Nagore, Daniel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8380594/
https://www.ncbi.nlm.nih.gov/pubmed/34278555
http://dx.doi.org/10.1007/s40744-021-00345-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8380594/
https://www.ncbi.nlm.nih.gov/pubmed/34278555
http://dx.doi.org/10.1007/s40744-021-00345-5

Ejemplares similares